Hanmi, Merck Collaborate To Evaluate BH3120 + Keytruda Combination In Metastatic Solid Tumors
(RTTNews) – Korea’s Hanmi Pharmaceutical said it has entered into a Clinical Trial Collaboration and Supply Agreement with Merck & Co., Inc. (MRK).
Symbol | Last Price | Change | % Change |
---|---|---|---|